In vitro interactions of licensed and novel antifungal drugs against Fusarium spp

Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for Management

Eleni Boutati, Elias Anaissie · Blood · 1997 · 563 citations · Full text

Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of <i>Aspergillus</i> spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

Michael A. Pfaller, S. A. Messer, R. J. Hollis et al. · Antimicrobial Agents and Chemotherapy · 2002 · 401 citations · Full text

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

Ihor Bekersky, Robert M. Fielding, Dawna Dressler et al. · Antimicrobial Agents and Chemotherapy · 2002 · 310 citations · Full text

Pharmaceutical Science, Amphotericin B Deoxycholate, Biochemistry +11

In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi

Ana Espinel‐Ingroff · Journal of Clinical Microbiology · 2001 · 291 citations · Full text

In Vitro Synergy of Caspofungin and Amphotericin B against <i>Aspergillus</i> and <i>Fusarium</i> spp

Sevtap Arıkan, Mario Lozano‐Chiu, Victor L. Paetznick et al. · Antimicrobial Agents and Chemotherapy · 2002 · 279 citations · Full text

Antifungal Agent, Health Sciences, Vitro Synergy +14